Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PIC Investment Group is a private family office and investment holding company based in Saskatoon, Saskatchewan. The firm manages a diverse portfolio of companies across several sectors, with a significant strategic focus on life sciences, biotechnology, and healthcare. PIC provides long-term equity capital and management support to its subsidiaries, which have included pioneers in medical cannabis, diagnostic metabolomics, and pharmaceutical distribution. Notable historical and current investments include CanniMed Therapeutics, Phenomenome Discoveries, and Can-Neth Pharmaceuticals. The group is a cornerstone of the Saskatoon biotechnology cluster, often taking lead roles in early-stage funding and governance for local innovation. Their healthcare interests span from chemical distribution for water treatment to advanced diagnostic tools for neurodegenerative diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PIC Investment Group.